CD39 and CD73 are expressed by cancer cells and different immune cell populations and are responsible for the regulation of the balance between proinflammatory ATP and immunosuppressive adenosine in the tumor microenvironment [48, 49, 90, 91]. This evidence concerns the gene ENTPD1 and neoplasm.